We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

News   Mar 12, 2018 | Original Story by Tim Stephens for the university of California Santa Cruz.

 
Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.

 
 
 

RELATED ARTICLES

Red Wine for the Red Planet

News

An ingredient in grapes may protect against musculoskeletal atrophy in partial gravity which could help astronauts travelling to Mars.

READ MORE

Radiation in Parts of Marshall Islands Higher Than Chernobyl

News

Evidence suggests residents should not return to several currently uninhabited islands where the United States conducted nuclear tests during the Cold War,until areas are thoroughly cleaned and further assessed for safety.

READ MORE

Preventing Eczema Skin Cracks Could Reduce Allergy Issues

News

Many babies with eczema go on to develop food allergies, asthma and hay fever, and researchers say it’s not a coincidence. The cracks caused by eczema weaken the skin barrier, allowing allergens to penetrate the skin and cause a sequence of allergic diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE